Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial

1. Subbiah, V.
2. Cassier, P.A.
3. Siena, S.
4. Garralda, E.
5. Paz-Ares, L.
6. Garrido, P.
7. Nadal, E.
8. Vuky, J.
9. Lopes, G.
10. Kalemkerian, G.P.
11. Bowles, D.W.
12. Seetharam, M.
13. Chang, J.
14. Zhang, H.
15. Green, J.
16. Zalutskaya, A.
17. Schuler, M.
18. Fan, Y.
19. Curigliano, G.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1038/S41591-022-01931-Y GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus